All articles by Alicia Ciccone
Teva is in the process of converting patients to a new, patent-protected version of Copaxone.
Researchers found that messenger chemical BDNF activated neurons in the amygdala where the memory is stored.
Since being instated in 1998, there has been a near 30% drop in NTD occurrences.
The study was the first to model the disease in a large animal with similar physiology to humans.
Savaysa is not recommended for patients with non-valvular atrial fibrillation with CrCL > 95 ml/min.
Kamil Ugurbil, PhD, is leading the monumental 5-year Human Connectome brain imaging project that’s making use of 7T MRI technology.
Rytary is meant to reduce “on” and “off” periods of Parkinson’s symptoms.
Stroke deaths are decreasing, but stroke occurrence is increasing, especially among younger populations.